A Study to Investigate a New Treatment in Patients With Parkinson's Disease

NCT03407378 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: IPT803
GENETIC: Optional pharmacogenetic assessment
OTHER: Questionnaires
OTHER: Optional Blood-Oxygen-level Dependent functionalMRI
OTHER: Motor Assessments before taking regular PD treatment
OTHER: Motor Assessments on regular PD treatment

Sponsor

Tools4Patient